Reaction

Stoma Site Dermatitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 33 reports · 2 co-occurring drugs

As of the last recalculation, Stoma Site Dermatitis appears in 33 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 1,852.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Teduglutide	18	1,852.4	1,854.9
Dimenhydrinate	14	1,438.5	1,440.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.